Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1728 | 6064 | 42.8 | 88% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
443 | 24079 | ACUTE PROMYELOCYTIC LEUKEMIA//ARSENIC TRIOXIDE//VITAMIN A |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
2398 | 2189 | ACUTE PROMYELOCYTIC LEUKEMIA//PML RAR ALPHA//APL |
4429 | 1714 | SUMO//SUMOYLATION//UBC9 |
10298 | 1009 | ARSENIC TRIOXIDE//AS2O3//ARSENIC TRIOXIDE AS2O3 |
15757 | 624 | DAXX//PML//PML NUCLEAR BODIES |
22099 | 337 | HIPK2//CACYBP SIP//CACYBP |
27292 | 191 | REALGAR//ALACRANITE//PARAREALGAR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ACUTE PROMYELOCYTIC LEUKEMIA | Author keyword | 649 | 66% | 10% | 607 |
2 | ARSENIC TRIOXIDE | Author keyword | 568 | 63% | 9% | 570 |
3 | SUMO | Author keyword | 239 | 54% | 5% | 306 |
4 | SUMOYLATION | Author keyword | 154 | 48% | 4% | 239 |
5 | PML RAR ALPHA | Author keyword | 138 | 76% | 2% | 96 |
6 | APL | Author keyword | 117 | 52% | 3% | 160 |
7 | UBC9 | Author keyword | 103 | 65% | 2% | 98 |
8 | ALL TRANS RETINOIC ACID | Author keyword | 88 | 26% | 5% | 298 |
9 | ACUTE PROMYELOCYTIC LEUKAEMIA | Author keyword | 82 | 60% | 1% | 89 |
10 | HIPK2 | Author keyword | 72 | 69% | 1% | 61 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ACUTE PROMYELOCYTIC LEUKEMIA | 649 | 66% | 10% | 607 | Search ACUTE+PROMYELOCYTIC+LEUKEMIA | Search ACUTE+PROMYELOCYTIC+LEUKEMIA |
2 | ARSENIC TRIOXIDE | 568 | 63% | 9% | 570 | Search ARSENIC+TRIOXIDE | Search ARSENIC+TRIOXIDE |
3 | SUMO | 239 | 54% | 5% | 306 | Search SUMO | Search SUMO |
4 | SUMOYLATION | 154 | 48% | 4% | 239 | Search SUMOYLATION | Search SUMOYLATION |
5 | PML RAR ALPHA | 138 | 76% | 2% | 96 | Search PML+RAR+ALPHA | Search PML+RAR+ALPHA |
6 | APL | 117 | 52% | 3% | 160 | Search APL | Search APL |
7 | UBC9 | 103 | 65% | 2% | 98 | Search UBC9 | Search UBC9 |
8 | ALL TRANS RETINOIC ACID | 88 | 26% | 5% | 298 | Search ALL+TRANS+RETINOIC+ACID | Search ALL+TRANS+RETINOIC+ACID |
9 | ACUTE PROMYELOCYTIC LEUKAEMIA | 82 | 60% | 1% | 89 | Search ACUTE+PROMYELOCYTIC+LEUKAEMIA | Search ACUTE+PROMYELOCYTIC+LEUKAEMIA |
10 | HIPK2 | 72 | 69% | 1% | 61 | Search HIPK2 | Search HIPK2 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SUMOYLATION | 335 | 61% | 6% | 358 |
2 | PML RAR ALPHA | 327 | 62% | 6% | 340 |
3 | T15 17 TRANSLOCATION | 327 | 78% | 4% | 215 |
4 | ACUTE PROMYELOCYTIC LEUKEMIA | 319 | 22% | 21% | 1283 |
5 | RAR ALPHA | 311 | 49% | 8% | 467 |
6 | TRANS RETINOIC ACID | 211 | 24% | 13% | 766 |
7 | PROTEIN SUMOYLATION | 194 | 82% | 2% | 112 |
8 | DIFFERENTIATION THERAPY | 184 | 54% | 4% | 234 |
9 | AS2O3 | 168 | 74% | 2% | 126 |
10 | PML | 165 | 36% | 6% | 372 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Concepts in sumoylation: a decade on | 2007 | 701 | 135 | 88% |
Sumoylation: A Regulatory Protein Modification in Health and Disease | 2013 | 99 | 216 | 83% |
Acute promyelocytic leukemia: from highly fatal to highly curable | 2008 | 394 | 81 | 94% |
The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition | 2010 | 279 | 132 | 88% |
SUMO: A history of modification | 2005 | 821 | 109 | 83% |
Protein modification by SUMO | 2004 | 888 | 194 | 82% |
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies | 2007 | 399 | 117 | 79% |
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet | 2009 | 254 | 115 | 79% |
Mechanisms, regulation and consequences of protein SUMOylation | 2010 | 172 | 160 | 81% |
Function and regulation of SUMO proteases | 2012 | 77 | 119 | 83% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UMR 7212 | 23 | 86% | 0.2% | 12 |
2 | SHANGHAI HEMATOL | 20 | 25% | 1.2% | 71 |
3 | NEW FRONTIER SCI | 13 | 62% | 0.2% | 13 |
4 | GLOBAL INITIAT PULSED POWER ENGN | 11 | 78% | 0.1% | 7 |
5 | CELLULAR SENESCENCE GRP | 8 | 60% | 0.1% | 9 |
6 | HUMAN GENETSLOAN KETTERING | 8 | 100% | 0.1% | 5 |
7 | MOL ONCOGENESIS | 7 | 19% | 0.5% | 32 |
8 | HARRY B AILEEN B GORDON DIABET | 6 | 80% | 0.1% | 4 |
9 | UMR 944 | 6 | 71% | 0.1% | 5 |
10 | CNRSUPR 9051 | 6 | 100% | 0.1% | 4 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000013954 | BRANCHIO OCULO FACIAL SYNDROME//RIZ1//BCL6 |
2 | 0.0000013097 | METHYLSULFONYLMETHANE//LEUKEMIA CELL DIFFERENTIATION//N ACETYL S N METHYLCARBAMOYLCYSTEINE |
3 | 0.0000012558 | VITAMIN A//RETINOIC ACID//RETINOIDS |
4 | 0.0000011912 | MYELODYSPLASTIC SYNDROMES//ACUTE MYELOID LEUKEMIA//LEUKEMIA |
5 | 0.0000011452 | PROTEASOME//UBIQUITIN//NEDD8 |
6 | 0.0000009044 | ARSENIC//ARSENIC SPECIATION//ARSENITE |
7 | 0.0000006850 | P73//MDM2//P53 |
8 | 0.0000006280 | GRANULOCYTIC SARCOMA//CHLOROMA//TUMOR LYSIS SYNDROME |
9 | 0.0000005959 | PROTEIN KINASE D//PROTEIN KINASE D PKD//MEF2C |
10 | 0.0000005941 | NUCLEAR ENVELOPE//NUCLEAR PORE COMPLEX//NUCLEAR LAMINA |